Global Genito-Urinary Drugs Market Report 2020 - Opportunities And Strategies, Market Forecast And Trends

14 Dec, 2020

Avail up to 50% off on ALL research reports at: Offer applies until Dec 31st!

The global genito-urinary drugs market is expected to decline from $54.2 billion in 2019 to $43.8 billion in 2020 at a compound annual growth rate (CAGR) of -19.3%. The decline is mainly due to the disruption caused by the lockdown measure across various countries to contain COVID-19 spread. Currently there is less demand for genito-urinary drugs mainly as people are staying at home and are less likely to get exposed to factors that might cause genito-urinary infections, or other hormonal diseases caused by lifestyle changes or eating habits. The market is then expected to recover and grow at a CAGR of 4% from 2021 and reach $61.4 billion in 2023.

The genito-urinary drugs market consists of sales of genito-urinary drugs and related services by entities (organizations, sole traders and partnerships) that produce genito-urinary drugs to treat genito- urinary diseases. This industry includes establishments that produce infertility drugs, hormonal contraceptives, erectile dysfunction drugs and hormonal replacement drugs to treat infertility, infections and prevent pregnancy. It also consists of establishments which produce drugs for benign prostatic hypertrophy, drugs for urinary incontinence and overactive bladder, diuretics to treat urinary calculi, cystic kidney disease, Reno vascular diseases, glomerular disorders and other urinary disorders.

Request For A Sample For The Global Genito-Urinary Drugs Market Report:

The global genito-urinary drugs market is further segmented based on type, distribution channel, route of administration, drug classification, mode of purchase and geography.
By Type: Hormonal Contraceptives, Drugs For Benign Prostatic hypertrophy, Drugs For Infertility, Drugs For Erectile Dysfunction, Drugs For Urinary Incontinence And Overactive Bladder, Drugs For Infections And Others, Drugs For Hormonal Replacement Therapy, Diuretics.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others.
By Route Of Administration: Oral, Parenteral, Others.
By Drug Classification: Branded Drugs, Generic Drugs.
By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs.
By Geography: The global genito-urinary drugs market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, the North American genito-urinary drugs market accounts for the largest share of 55% in the global genito-urinary drugs market 2019.

Read More On The Report For The Global Genito-Urinary Drugs Market At:

Trends In The Genito-Urinary Drugs Market
The launch of combination products for the treatment of urinary tract infections is an emerging trend in the genito-urinary disorder drugs market. Competitors in the market are developing combination drugs to fight multi-drug resistant bacteria and also expanding indications for existing drugs for the treatment of genito-urinary disorders.
Genito-Urinary Drugs Global Market Report 2020 is one of a series of new reports from The Business Research Company that provides genito-urinary drugs market overviews, analyzes and forecasts market size and growth for the global genito-urinary drugs market, genito-urinary drugs market share, genito-urinary drugs market players, genito-urinary drugs market segments and geographies, genito-urinary drugs market’s leading competitors’ revenues, profiles and market shares. The genito-urinary drugs market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.